Published in Gene Therapy Weekly, February 16th, 2012
"Specifically, the SNCG transcript was targeted by SNCG-shRNA lentiviral particles designed to silence SNCG...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.